Business
Novo Nordisk’s Wegovy sales exceeded expectations
The pharmaceutical giant has narrowed its full-year forecast after blockbuster weight-loss drug Wegovy beat sales expectations in the third quarter.
The pharmaceutical giant has narrowed its full-year forecast after blockbuster weight-loss drug Wegovy beat sales expectations in the third quarter.
